跳至主要内容
临床试验/NCT05047068
NCT05047068进行中(未招募)不适用

OCS Heart Perfusion (OHP) Post-Approval Registry

TransMedics27 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2021年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
TransMedics
入组人数
350
试验地点
27
主要终点
Patient Survival

研究概览

简要总结

The objective of this post-approval registry is to provide additional real-world evidence of the performance of the OCS Heart System to preserve DBD and DCD donor hearts.

详细描述

Multi-center, observational post-approval registry to:

  1. compare patient and graft survival of adult primary heart transplant recipients receiving DBD donor hearts perfused and assessed on the OCS Heart System compared to adult recipients of DBD donor hearts preserved using ischemic cold storage hearts (Control) at the same Registry centers over the same time period, and
  2. compare patient and graft survival of adult primary heart transplant recipients receiving DCD donor hearts perfused and assessed on the OCS Heart System compared to adult recipients of DBD donor hearts preserved using ischemic cold storage hearts (Control) at the same Registry centers over the same time period.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult primary heart transplant recipients of DBD or DCD donor hearts perfused on the OCS Heart System.

排除标准

  • Concurrent (multi-organ transplant) or previous solid organ or bone marrow transplant; or
  • On renal dialysis at time of transplant.
  • Donor Exclusion Criteria (for DCD Donor Hearts only):
  • Warm ischemic time > 30 minutes (warm ischemic time is defined as: Time from when mean systolic blood pressure (SBP) is < 50 mmHg or peripheral saturation < 70% to aortic cross-clamp and administration of cold cardioplegia in the donor).

结局指标

主要结局

Patient Survival

时间窗: One year post-heart transplant

Patient survival at one-year post-heart transplant.

次要结局

未报告次要终点

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (27)

Loading locations...

相似试验